Summary
Jefferies & Company, Inc. (Jefferies) is a global securities and investment banking company. It operates as a subsidiary of Jefferies Group, Inc. It offers institutional brokerage, capital market and financial advisory services, securities research and wealth and asset management services to high net worth individual, institutional investor and corporate clients. Jefferies provides advisory services in the field of mergers and acquisitions, equity and equity-linked financing, leveraged finance, and restructuring solutions. It caters to various industries such as energy, aerospace and defense, business services, gaming and leisure, industrials, healthcare, lodging and real estate, maritime, media, technology and telecommunications. The company has operations across the US and one representative office in China. Jefferies is headquartered in New York, the US.
GlobalData’s Jefferies & Company, Inc. (JEF) - Medical Equipment - Advisory Profile provides an overview of the deals advised by Jefferies & Company, Inc. in the Medical Equipment market. The report is an essential source of information for Medical Equipment companies, which require the services of financial/legal advisors in their area/region for raising capital or acquiring a company. The report summarizes Jefferies & Company, Inc.'s deals for the past five years segregated into year, deal type, segment and geography.
Scope
- Provides essential information on the financial deals in which the firm provided financial/legal advisory services. The deals include mergers and acquisitions, asset financing, asset transactions, private equity / venture capital deals, equity offerings, debt offerings, partnerships, and licensing agreements
- Outlines key advisor information for business intelligence needs such as name, business overview, location and contact information
- Analyzes the advisor’s deals by year, deal type, segment and geography
- Provides detailed information on deal particulars, including information about other advisors involved in the deal
- Includes information on the role played by the advisor in specific deals, and the extent of fees/commission charged by the advisor in a particular transaction, if disclosed
- Consists of Deals Advised by Year chart and table displaying information on the number of deals and value reported by the advisor by year, for a five year period
- Incorporates information on the major recent financial deals of the advisor. Each such deal carries a summary, deal type, deal rationale, deal financials and target company’s key financial metrics and ratios (financials are available for major public companies).
Reasons to Buy
- Receive detailed information and evaluate the profile of a particular advisor in the market before considering for your business needs
- Peruse all the advisor’s deals in the Industry market
- Access detailed information about the advisor’s financial deals for the past five years that enable you to scrutinize the key deals, which have shaped investment policies
- Identify other potential advisors currently active in your industry, or industry that you wish to foray into
- Compare your advisory services vis-à-vis your competitors’
- Check and identify the advisor that suits your requirements, such as placement agents, book-runners and underwriters
- Examine the breakdown of deals by category and detailed information on major deals incorporated in the advisor’s profile for your academic or business research needs and their suitability to your requirements.
Medical Equipment And Supply Industry in the United States
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Jefferies & Company, Inc., Medical Equipment Deals Advised By Year, 2007 to YTD 2013 7
Jefferies & Company, Inc., Medical Equipment Deals Advised By Type, 2007 to YTD 2013 8
Jefferies & Company, Inc., Medical Equipment Deals Advised By Region, 2007 to YTD 2013 9
Jefferies & Company, Inc., Medical Equipment Deals Advised By Market, 2007 to YTD 2013 10
Jefferies & Company, Inc., Medical Equipment Deals Advised Summary, 2007 to YTD 2013 12
Jefferies & Company, Inc., Medical Equipment, Deal Details 19
Acquisition 19
Automatic Data Processing Acquires AdvancedMD 19
The ConJoin Group Acquires PHNS 21
3M Company Completes Acquisition Of Arizant From Court Square Capital 22
Sonova Holding Acquires Advanced Bionics 24
AMICAS Acquires Emageon 26
Baxter International Completes Acquisition Of Baxa For $380 Million 27
Align Technology Completes Acquisition Of Cadent 29
Covidien Completes Acquisition Of Power Medical Interventions 32
Berwind Acquires Oliver Products, Developer Of Sterile Medical Device, From Mason Wells 34
Tunstall Healthcare Completes Acquisition Of American Medical Alert For $82 Million 35
BioScrip Completes Acquisition Of Critical Homecare Solutions From Kohlberg & Company 37
MedAssets Completes The Acquisition Of Broadlane From TowerBrook 39
DSM Completes Acquisition Of Kensey Nash, Regenerative Medicine Company, For $360 Million 41
Baxter International Completes Acquisition Of Prism Pharma For $338 Million 43
MedQuist And Cbay Complete The Acquisition Of Spheris 45
Nuance Communications Acquires eScription 47
Bausch & Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For $631 Million 49
Myriad Genetics Acquires Rules-Based Medicine 51
Philips Healthcare Acquires Discus Holdings 53
Dainippon Sumitomo Pharma Completes Acquisition Of Sepracor For $2.6 Billion 55
General Dynamics Acquires ViPs From HLTH 57
AssuraMed Completes Acquisition Of Invacare Supply Group From Invacare For $151 Million 59
Affymetrix Completes Acquisition Of eBioscience For $315 Million 61
Hologic Acquires Cytyc For $6,200 Million 63
Roper Industries Completes Acquisition Of Sunquest Information Systems, Healthcare IT Company, For $1.42 Billion 65
Pall Corporation Completes Acquisition Of ForteBio For $142.5 Million 67
Hologic Acquires Biolucent 69
Asset Transactions 70
Trinity Biotech Completes Sale Of Coagulation Business To Diagnostica Stago 70
Kimberly-Clark Completes Acquisition Of Pain Management Business From Baylis Medical Company 72
Debt Offerings 73
Valeant Pharma Completes Public Offering Of Senior Unsecured Notes Due 2020 For $700 Million 73
Valeant Pharma Completes Private Placement Of Senior Unsecured Notes For $400 Million 75
Lantheus Medical Imaging Completes Private Placement Of 9.75% Senior Unsecured Notes For $150 Million 76
Catalent Pharma Solutions Completes Private Placement Of Senior Notes Due 2018 For $350 Million 77
Inverness Medical Innovations Completes Public Offering Of 7.88% Senior Notes For $150 Million 78
Alere Completes Private Placement Of Senior Subordinate Notes For $400 Million 79
Hanger Orthopedic Completes Private Placement Of Senior Notes Due 2018 For $200 Million 80
Teleflex Completes Underwritten Public Offering Of 3.875% Convertible Senior Subordinated Notes For $400 Million 81
Valeant Pharma Completes Public Offering Of Senior Unsecured Notes Due 2017 For $500 Million 83
RadNet Completes Private Placement Of 10.375% Senior Unsecured Notes For $200 Million 85
Inverness Medical Innovations Completes Private Placement Of Senior Notes For $100 Million 86
Lantheus Medical Imaging Completes Private Placement 9.75% Senior Notes For $250 Million 87
Equity Offerings 88
Power Medical Interventions Completes IPO Of $42.35 Million 88
MannKind Completes Public Offering Of Shares For $67 Million 89
MannKind Completes Public Offering Of Common Stock And Warrants For $92 Million 91
Cytori Therapeutics Completes Exercise Of Underwriters’ Overallotment Option For $21 Million 93
AMAG Pharma Completes Public Offering Of $162.85 Million 95
SEQUENOM Completes Private Placement Of Common Stock For $51.6 Million 97
Mindray Medical International Completes Public Offering Of $152.8 Million 99
Unilife Completes Public Offering Of Common Stock For $20 Million 101
Unilife Completes Public Offering Of Common Stock For $35.9 Million 102
Celldex Therapeutics Prices Public Offering Of Common Stock For $90 Million 104
Exact Sciences Completes Underwritten Public Offering Of $69 Million 106
Celldex Therapeutics Completes An Underwritten Public Offering Of $32 Million 108
OPKO Health Completes Exercise Of Underwriters’ Over-allotment Option For $110 Million 110
OraSure Technologies Completes Public Offering Of Common Stock For $75 Million 112
Emdeon Completes IPO Of $166.24 Million 114
Alphatec Holdings Completes Underwritten Public Offering Of Common Stock For $46 Million 116
DynaVox Completes IPO For $140.6 Million 118
BioForm Medical Completes IPO Of $92 Million 120
AcelRx Pharma Completes Underwriters' Exercise Of Over-Allotment Option For $6 Million 121
Celldex Therapeutics Completes Underwriters' Exercise Of Over-Allotment Option For $46 Million 123
Inverness Medical Innovations Completes Public Offering Of $838.37 Million 125
Inverness Medical Innovations Completes Public Offering Of $273.59 Million 127
Sagent Pharma Completes IPO Of $106 Million 129
Sequenom Completes Public Offering Of $96.6 Million 131
Cerus Completes Underwritten Public Offering Of $21 Million 133
Exact Sciences Completes Public Offering of Common Stock For $62 Million 135
MannKind Completes Public Offering Of Units For $86 Million 137
Delcath Systems Completes Public Offering Of Common Stock For $25.3 Million 139
WuXi PharmaTech Completes IPO Of $167.7 Million 141
Medidata Solutions Completes IPO Of $101.43 Million 143
athenahealth Completes IPO Of $90 Million 145
Sequenom Completes Public Offering Of Common Stock For $62 Million 147
Danaher Completes Public Offering Of Common Stock For $996.18 Million 149
Merger Deals 151
Accelrys Completes Merger With Symyx Technologies 151
MSC Care Management Completes Merger With One Call Medical 153
Private Equity 155
ABRY Partners Invests $85 Million In Automated HealthCare Solutions 155
HLTH Sells Porex To Aurora Capital 156
MSD Capital And North Peak Capital Acquire Dental One From SSM Partners And ABN Amro Cpaital 157
Citi Venture Capital Completes Acquisition Of Ness Technologies For $307 Million 158
GTCR Acquires Sterigenics International From Silverfleet Capital And PPM America 160
Warburg Pincus Completes Acquisition Of ReSearch Pharma Services 162
Huntsman Gay Global Acquires 51% Stake In Sunquest Information From Vista Equity Partners 164
JLL Partners Completes Acquisition Of American Dental Partners For $398 Million 165
Venture Financing 167
Palmaz Scientific Raises Additional $4.7 Million In Venture Financing Round 167
Appendix 168
Methodology 168
About GlobalData 168
Contact Us 168
Disclaimer 168
List of Tables
Jefferies & Company, Inc., Key Facts 1
Jefferies & Company, Inc., Medical Equipment Deals Advised Summary, 2007 to YTD 2013 1
Jefferies & Company, Inc., Medical Equipment Deals Advised By Year, 2007 to YTD 2013 7
Jefferies & Company, Inc., Medical Equipment Deals Advised By Type, 2007 to YTD 2013 8
Jefferies & Company, Inc., Medical Equipment Deals Advised By Region, 2007 to YTD 2013 9
Jefferies & Company, Inc. Deals Advised By Market, 2007 to YTD 2013 10
Jefferies & Company, Inc., Medical Equipment Deals Advised Summary, 2007 to YTD 2013 12
Automatic Data Processing Acquires AdvancedMD 19
The ConJoin Group Acquires PHNS 21
3M Company Completes Acquisition Of Arizant From Court Square Capital 22
Sonova Holding Acquires Advanced Bionics 24
AMICAS Acquires Emageon 26
Baxter International Completes Acquisition Of Baxa For $380 Million 27
Align Technology Completes Acquisition Of Cadent 29
Covidien Completes Acquisition Of Power Medical Interventions 32
Berwind Acquires Oliver Products, Developer Of Sterile Medical Device, From Mason Wells 34
Tunstall Healthcare Completes Acquisition Of American Medical Alert For $82 Million 35
BioScrip Completes Acquisition Of Critical Homecare Solutions From Kohlberg & Company 37
MedAssets Completes The Acquisition Of Broadlane From TowerBrook 39
DSM Completes Acquisition Of Kensey Nash, Regenerative Medicine Company, For $360 Million 41
Baxter International Completes Acquisition Of Prism Pharma For $338 Million 43
MedQuist And Cbay Complete The Acquisition Of Spheris 45
Nuance Communications Acquires eScription 47
Bausch & Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For $631 Million 49
Myriad Genetics Acquires Rules-Based Medicine 51
Philips Healthcare Acquires Discus Holdings 53
Dainippon Sumitomo Pharma Completes Acquisition Of Sepracor For $2.6 Billion 55
General Dynamics Acquires ViPs From HLTH 57
AssuraMed Completes Acquisition Of Invacare Supply Group From Invacare For $151 Million 59
Affymetrix Completes Acquisition Of eBioscience For $315 Million 61
Hologic Acquires Cytyc For $6,200 Million 63
Roper Industries Completes Acquisition Of Sunquest Information Systems, Healthcare IT Company, For $1.42 Billion 65
Pall Corporation Completes Acquisition Of ForteBio For $142.5 Million 67
Hologic Acquires Biolucent 69
Trinity Biotech Completes Sale Of Coagulation Business To Diagnostica Stago 70
Kimberly-Clark Completes Acquisition Of Pain Management Business From Baylis Medical Company 72
Valeant Pharma Completes Public Offering Of Senior Unsecured Notes Due 2020 For $700 Million 73
Valeant Pharma Completes Private Placement Of Senior Unsecured Notes For $400 Million 75
Lantheus Medical Imaging Completes Private Placement Of 9.75% Senior Unsecured Notes For $150 Million 76
Catalent Pharma Solutions Completes Private Placement Of Senior Notes Due 2018 For $350 Million 77
Inverness Medical Innovations Completes Public Offering Of 7.88% Senior Notes For $150 Million 78
Alere Completes Private Placement Of Senior Subordinate Notes For $400 Million 79
Hanger Orthopedic Completes Private Placement Of Senior Notes Due 2018 For $200 Million 80
Teleflex Completes Underwritten Public Offering Of 3.875% Convertible Senior Subordinated Notes For $400 Million 81
Valeant Pharma Completes Public Offering Of Senior Unsecured Notes Due 2017 For $500 Million 83
RadNet Completes Private Placement Of 10.375% Senior Unsecured Notes For $200 Million 85
Inverness Medical Innovations Completes Private Placement Of Senior Notes For $100 Million 86
Lantheus Medical Imaging Completes Private Placement 9.75% Senior Notes For $250 Million 87
Power Medical Interventions Completes IPO Of $42.35 Million 88
MannKind Completes Public Offering Of Shares For $67 Million 89
MannKind Completes Public Offering Of Common Stock And Warrants For $92 Million 91
Cytori Therapeutics Completes Exercise Of Underwriters’ Overallotment Option For $21 Million 93
AMAG Pharma Completes Public Offering Of $162.85 Million 95
SEQUENOM Completes Private Placement Of Common Stock For $51.6 Million 97
Mindray Medical International Completes Public Offering Of $152.8 Million 99
Unilife Completes Public Offering Of Common Stock For $20 Million 101
List of Figures
Jefferies & Company, Inc., Medical Equipment Deals Advised by Deal Type, 2007 to YTD 2013 1
Jefferies & Company, Inc., Medical Equipment Deals Advised By Year, 2007 to YTD 2013 1
Jefferies & Company, Inc., Medical Equipment Deals Advised By Region, 2007 to YTD 2013 1
Jefferies & Company, Inc., Medical Equipment Deals Advised By Market, 2007 to YTD 2013 1
Jefferies & Company, Inc., Medical Equipment Deals Advised By Year, 2007 to YTD 2013 7
Jefferies & Company, Inc., Medical Equipment Deals Advised by Deal Type, 2007 to YTD 2013 8
Jefferies & Company, Inc., Medical Equipment Deals Advised By Region, 2007 to YTD 2013 9
Jefferies & Company, Inc., Medical Equipment Deals Advised by Market, 2007 to YTD 2013 10
